Literature DB >> 9892009

Roles of pathway-specific and inhibitory Smads in activin receptor signaling.

J J Lebrun1, K Takabe, Y Chen, W Vale.   

Abstract

Activins and other members of the transforming growth factor-beta-like superfamily of growth factors transduce their signals by interacting with two types of receptor serine/threonine kinases. The Smad proteins, a new family of intracellular mediators are involved in the signaling pathways of these receptors, but the initial stages of their activation as well as their specific functions remain to be defined. We report here that the pathway-specific Smad2 and 3 can form a complex with the activin receptor in a ligand-dependent manner. This complex formation is rapid but also transient. Indeed, soon after their association with the activin receptor, Smad2 and Smad3 are released into the cytoplasm where they interact with the common partner Smad4. These Smad complexes then mediate activin-induced transcription. Finally, we show that the inhibitory Smad7 can prevent the association of the two pathway-specific Smads with the activin receptor complex, thereby blocking the activin signal.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892009     DOI: 10.1210/mend.13.1.0218

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  30 in total

1.  Structural basis for the functional difference between Smad2 and Smad3 in FAST-2 (forkhead activin signal transducer-2)-mediated transcription.

Authors:  R P Nagarajan; Y Chen
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

2.  Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling.

Authors:  H Kaji; L Canaff; J J Lebrun; D Goltzman; G N Hendy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Activin and glucocorticoids synergistically activate follicle-stimulating hormone beta-subunit gene expression in the immortalized LbetaT2 gonadotrope cell line.

Authors:  Shauna M McGillivray; Varykina G Thackray; Djurdjica Coss; Pamela L Mellon
Journal:  Endocrinology       Date:  2006-11-02       Impact factor: 4.736

4.  Quantitative Proteomics of the SMAD (Suppressor of Mothers against Decapentaplegic) Transcription Factor Family Identifies Importin 5 as a Bone Morphogenic Protein Receptor SMAD-specific Importin.

Authors:  Roy Baas; Ayestha Sijm; Hetty A A M van Teeffelen; Robert van Es; Harmjan R Vos; H Th Marc Timmers
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

5.  The Local Control of the Pituitary by Activin Signaling and Modulation.

Authors:  Louise M Bilezikjian; Wylie W Vale
Journal:  Open Neuroendocrinol J       Date:  2011-01-01

6.  Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.

Authors:  F Itoh; H Asao; K Sugamura; C H Heldin; P ten Dijke; S Itoh
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

Review 7.  Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin.

Authors:  Louise M Bilezikjian; Nicholas J Justice; Alissa N Blackler; Ezra Wiater; Wylie W Vale
Journal:  Mol Cell Endocrinol       Date:  2012-02-04       Impact factor: 4.102

8.  Phylogenomic analyses reveal the evolutionary origin of the inhibin alpha-subunit, a unique TGFbeta superfamily antagonist.

Authors:  Jie Zhu; Edward L Braun; Satomi Kohno; Monica Antenos; Eugene Y Xu; Robert W Cook; S Jack Lin; Brandon C Moore; Louis J Guillette; Theodore S Jardetzky; Teresa K Woodruff
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

9.  Kdm6b and Pmepa1 as Targets of Bioelectrically and Behaviorally Induced Activin A Signaling.

Authors:  Andrea S Link; Svitlana Kurinna; Steven Havlicek; Sandra Lehnert; Martin Reichel; Johannes Kornhuber; Beate Winner; Tobias Huth; Fang Zheng; Sabine Werner; Christian Alzheimer
Journal:  Mol Neurobiol       Date:  2015-07-28       Impact factor: 5.590

10.  Smad7 Regulates Dental Epithelial Proliferation during Tooth Development.

Authors:  Z Liu; T Chen; D Bai; W Tian; Y Chen
Journal:  J Dent Res       Date:  2019-09-09       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.